Discovery Laboratories, Inc. (DSCO)

Discovery Labs is another biotechnology company who does things I can't pronounce or spell so I should stay away. It has my attention due to FDA rulings that are due soon (April 17th). So if you're reading this after then I'm either a FOOL or a "fool" for following the pied piper. At this point it's drug to prevent respiratory distress syndrome (RDS) in infants has had several set backs due to manufactureability and delivery mechanisms. It's very difficult to deliver the right amount of a drug that is airborne, especially when your target is very, very, small! They have been working on the delivery mechanism and are ready to try again with the FDA. Normally I stay away from biotechs as the road is long and the FDA has the power to set things back by months or years or kill the product out right. In this case it was not the drug that was in question, but the delivery and dosage. The drug has it's 3rd approval letter from the FDA, but had a six month inquiry period rather than the two months that had been hopef for by investors. Favorable results and the biotech stock soars on $$ signs based on cryptic math or buyout opportunities, bad results or FDA in a bad move and the stock dives. In this case I put real money on Discovery Labs. Maybe my glasses are fogged from Dendreon this week.....
Betting for bio's at least is betting for the human side of things while hoping for the monetary gain!

I think they might have messed up enough to finally get their product to market